GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (OTCPK:IPDQF) » Definitions » Days Sales Outstanding

IPDQF (Impedimed) Days Sales Outstanding : 73.65 (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Impedimed Days Sales Outstanding?

Impedimed's average Accounts Receivable for the six months ended in Dec. 2024 was $1.53 Mil. Impedimed's Revenue for the six months ended in Dec. 2024 was $3.79 Mil. Hence, Impedimed's Days Sales Outstanding for the six months ended in Dec. 2024 was 73.65.

The historical rank and industry rank for Impedimed's Days Sales Outstanding or its related term are showing as below:

IPDQF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.24   Med: 68.39   Max: 102.19
Current: 74.59

During the past 13 years, Impedimed's highest Days Sales Outstanding was 102.19. The lowest was 40.24. And the median was 68.39.

IPDQF's Days Sales Outstanding is ranked worse than
60.22% of 812 companies
in the Medical Devices & Instruments industry
Industry Median: 66.395 vs IPDQF: 74.59

Impedimed's Days Sales Outstanding declined from Dec. 2023 (89.63) to Dec. 2024 (73.65).


Impedimed Days Sales Outstanding Historical Data

The historical data trend for Impedimed's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impedimed Days Sales Outstanding Chart

Impedimed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.21 61.01 70.50 71.43 79.18

Impedimed Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85.10 91.35 89.63 71.17 73.65

Competitive Comparison of Impedimed's Days Sales Outstanding

For the Medical Devices subindustry, Impedimed's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Impedimed's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Impedimed's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Impedimed's Days Sales Outstanding falls into.


;
;

Impedimed Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Impedimed's Days Sales Outstanding for the fiscal year that ended in Jun. 2024 is calculated as

Days Sales Outstanding (A: Jun. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Jun. 2024 )) / count ) / Revenue (A: Jun. 2024 )*Days in Period
=( (1.608 + 1.288) / 2 ) / 6.675*365
=1.448 / 6.675*365
=79.18

Impedimed's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (1.288 + 1.767) / 2 ) / 3.785*365 / 2
=1.5275 / 3.785*365 / 2
=73.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Impedimed  (OTCPK:IPDQF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Impedimed Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Impedimed's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Impedimed Business Description

Traded in Other Exchanges
Address
50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognizes revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.

Impedimed Headlines

From GuruFocus

Q3 2024 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 09-14-2024

ImpediMed Ltd Corporate Call Transcript

By GuruFocus Research 02-14-2024

Q3 2022 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Q3 2021 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2020 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2023 ImpediMed Ltd Cashflow Reports Call Transcript

By GuruFocus Research 02-14-2024

Half Year 2024 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 09-14-2024

Q3 2023 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024